Basic Information
BREZTRI AEROSPHERE PRESSURISED INHALATION SUSPENSION 160 MCG/7.2 MCG/5 MCG per actuation
AEROSOL, METERED
Regulatory Information
SIN16723P
March 2, 2023
Prescription Only
Therapeutic
RESPIRATORY (INHALATION)
August 10, 2023
May 30, 2025
XR03AL11
Company Information
Active Ingredients
Budesonide
Strength: 160 μg/actuation
Glycopyrronium bromide eqv Glycopyrronium
Strength: 7.2 μg/actuation
Formoterol fumarate dihydrate
Strength: 5.0 μg/actuation
Detailed Information
Contraindications
**4.3 Contraindications** Hypersensitivity to the active substances or any of the excipients.
Indication Information
**4.1 Therapeutic indications** Maintenance treatment to relieve symptoms and prevent exacerbations in adult patients with moderate to very severe chronic obstructive pulmonary disease (COPD) (see Section 5.1 – _please refer to the Product Insert/Patient Information Leaflet published on HSA for the full drug information_).